The potential use of methotrexate in the treatment of falciparum malaria: In vitro assays against sensitive and multidrug-resistant falciparum strains

Japanese Journal of Infectious Diseases

Volumn 61, Issue 3, 2008, Pages 210-211

  Dar, O ^a   Khan, Mishal S ^b   Adagu, I ^b  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; METHOTREXATE;

ANTIBIOTIC SENSITIVITY; ANTIMALARIAL ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; IC 50; IN VITRO STUDY; MALARIA FALCIPARUM; MULTIDRUG RESISTANCE; NONHUMAN; PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX;

ANIMALS; ANTIMALARIALS; CHLOROQUINE; DRUG RESISTANCE, MULTIPLE; HUMANS; HYPOXANTHINE; MALARIA, FALCIPARUM; METHOTREXATE; NUCLEIC ACID SYNTHESIS INHIBITORS; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; TRITIUM;

EID: 45849089601     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. World Health Organization (2002): Communicable Diseases 2002. Global Defense against the Infectious Disease Threat. p. 176. World Health Organization.
2. Schuster, B.G. and Milhous, W.K. (1993): Reduced resources applied, to antimalarial drug development. Parasitol. Today, 9, 167-168.
3. Hausknecht, R.U. (1995): Methotrexate and misoprostol to terminate early pregnancy. N. Engl. J. Med., 333, 537-540.
4. Warhurst, D.C., Steele, J.C.P., Adagu, I.S., et al. (2003): Hydroxychloroquine is much less active that chlorequine against chloroquine-resistant Plasmodium falciparum, in agreement with its physiochemical properties. J. Antimicrob. Chemother., 52, 188-193.
5. Dollery, C. (1998): Therapeutic Drugs. 2nd ed. Churchill Livingstone.
6. Fidock, D.A. and Wellems, T.E. (1997): Transformation with human dihydrofolate reductase renders malaria parasites insensitive to WR99210 but does not affect the intrinsic activity of proguanil. Proc. Natl. Acad. Sci. USA, 94, 10931-10936.
7. Sheehy, T.W. and Dempsey, H. (1970): Methotrexate therapy for Plasmodium vivax malaria. JAMA, 214, 109-114.
8. Sundar, S., Jha, T.K., Thakur, C.P., et al. (2006): Oral miltefosine for the treatment of Indian visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg., 100, Suppl. 1, S26-33.
9. Soto, J. and Berman, J. (2006): Treatment of new world cutaneous leishmaniasis with miltefosine. Trans. R. Soc. Trop. Med. Hyg., 100, Suppl. 1, S34-40.
10. Verma, N.K. and Dey, C.S. (2004): Possible mechanism of miltefosine-mediated death of Leishmania donovani. Antimicrob. Agents Chemother., 48, 3010-3015.